Upregulation of ARHGAP9 is correlated with poor prognosis and immune infiltration in clear cell renal cell carcinoma

Yu-Ling Xiong,Chao Peng,Yue Tian
DOI: https://doi.org/10.1097/md.0000000000039968
IF: 1.6
2024-10-09
Medicine
Abstract:Renal cell carcinoma (RCC) is among the 10 most common cancers worldwide, [ 1 ] of which clear cell renal cell carcinoma (ccRCC) represents the most common renal cancer histology and accounts for most cancer-related deaths. [ 2 ] Around 30% of ccRCC patients have metastases at initial presentation, [ 3 ] the poor prognosis of ccRCC is partly attributable to tumor metastasis. [ 4 , 5 ] Although many therapeutic strategies have been applied to ccRCC, advanced ccRCC is a lethal disease, portending a 5-year survival of <10%. [ 6 ] ccRCC is reported highly resistant to chemotherapy and radiotherapy. Therefore, it is urgent to explore effective therapeutic strategies and novel useful biomarkers for diagnosis and prognosis prediction of ccRCC. [ 7 ]
medicine, general & internal
What problem does this paper attempt to address?